Since persistent stress conditions typically characterize the TME, the TRAF2-sustained ER stress response aids cancer cells and other TME components adapt to ER stress induced by chemotherapeutic agents, thus avoiding apoptosis and promoting chemoresistance [96]. This evidence concerns the gene TRAF2 and cancer.